What's happening in and around the Park? Here's an update from the team at the Illinois Science + Technology Park.    
Chicago Health Care and Life Sciences Real Estate Conference @ISTP
Chicagoland is a leader in healthcare and an emerging life sciences hub. Attendees gained exclusive insights into the latest trends and actionable strategies to incorporate old and new techniques to improve the overall patient experience.

The program covered the future of Chicago’s life sciences sector as thought leaders discussed where the future of the asset class is headed. What does the market need for continued growth and expansion and what challenges are being faced? Industry leaders discussed how owners and developers are capitalizing on the healthcare and life sciences industries.
Topics included:

CHICAGOLAND’S EMERGENCE AS A LIFE SCIENCES HUB - How the City is Positioning Itself to Attract Highly Sought-After Investment and Best-in-Class Innovation

HEALTHCARE REPORT - Dissecting Chicagoland's Development Pipeline, Tech and Operations, the Latest Innovations, and More!

Best Practices for New-Build Facilities and Adaptive Reuse Lab Space

Skokie Homewood Suites by Hilton
A groundbreaking ceremony for the Skokie Homewood Suites by Hilton took place on 8/11. Representatives from the community, the Village of Skokie, construction management and hotel development noted their visions and contributions.

The development will include -

• 143 rooms, each with a private kitchenette
• 10,000 square foot indoor/outdoor event space with a capacity of 300
• Suites to accommodate long term stays
• A rooftop bar with views of the Chicago Skyline and Lake Michigan
• Pedestrian arcade to highlight the community
• Ground floor retail (tenants TBD) with rotating pastries and savory snacks.
On August 17th, tenants and employees of the Illinois Science and Technology Park are invited to learn more and provide input for the Skokie Homewood Suites by Hilton. The open house will be held from 10:45a to 12:30p in the AB Conference Room. at the Park.

The developers are seeking input concerning:
• Proposed usage for business functions, private events and conferences
• Expectation of digital infrastructure required
• Other amenities that would be beneficial
• Thoughts on retail tenants

Questions, email Emily Meyer of E&M Strategic Development
Space Now Available @ISTP
There is laboratory and office space available in 8045 Lamon.  Suites, ranging from approximately 10,000 sq. ft. to over 50,000 sq. ft., are ready now. Options appropriately address your access and security concerns.  Interested? Click here!

8045 Lamon (Research to Commercialization)
  • 4 story, 163,000 square feet
  • Gold LEED rated “green” facility
  • Conference Center and Auditorium
  • Areas for meetings, collaboration and socialization

Design your customized lab & office facilities at 8030 Lamon. (Flexible Options for Development)
  • Flexible build to suit options
  • Up to 200,000 square feet of office and development space

“The Illinois Science + Technology Park is a significant contributor to Skokie’s employment base and economic growth,” said Skokie Mayor George Van Dusen. “The park continues to grow and contribute to Skokie’s economy while also providing economic stimulus for the state and Midwest region.”
Highpoint at 8000 Reaches 50% Leased
Luxury Living Chicago Realty announced that Skokie’s newest luxury apartment building is over 50 percent leased. Located in Downtown Skokie at 8000 Lincoln Ave, the 12-story property features 153-units, an impressive suite of amenities, and ground-floor retail.

Highpoint at 8000 North’s unique juxtaposition of esteemed traditional architecture from Lucien Lagrange delivers luxuriously appointed and contemporary natural light-filled interiors. The property lends residents the opportunity to experience metropolitan elegance within the convenient downtown Skokie location.

“We could not be happier with the reception Highpoint has received,” said John Murphy, Chairman and CEO of Murphy Real Estate Services, the lead developer for the project. “Recognizing the exceptional location, architectural details and amenities within, the market response to Highpoint has exceeded expectations and realizes the planning and vision that the Village of Skokie developed for the community.”
Vetter: New Video Series on Planning a Successful Clinical Batch
The pivot from preclinical development to in-human trials is one of the most important transitions in the early life cycle of an injectable medication. A key step: Producing a batch of clinical material to support your in-human trials. In this series, Vetter experts will explain how your team can plan an efficient, streamlined clinical batch project that sets you up for success in your trials and beyond.

3 preview videos are available:

Preparing for clinical filling
See what you need to know, what you need to plan for, and how to strike the right balance between efficiency and quality.

Creating a product stability strategy
Understand the different approaches you can take to address product stability limits and learn how to identify the right option for your molecule and development strategy.

cGMP for your clinical batch
Learn why manufacturing best practices are critically important to your first fill finish projects, and how to start building a comprehensive quality system for your molecule.

Sharpen your skills and enhance your fill finish projects with expert guidance and strategic know-how.

To get more information and register for this program, click here.
LanzaTech Bacteria Carbon Capture Technology
LanzaTech, has been recycling carbon emissions into products such as clothes, aviation fuel, fragrances, and perfumes.

The patented CarbonSmart technology has shown how its carbon capture and conversion technology can do away with virgin fossil fuels to make things people use in their daily lives.

The major products made by LanzaTech out of its carbon recycling technology include the following:

  • Materials
  • Polymers
  • Monomers
  • Fragrances
  • Solvents
  • Protein
  • Chemicals (100+)
  • Fuels (SAF)

For every ton of CarbonSmart product made 2 tons of CO2 is removed. The scalable tech has the potential to produce >1 billion tons/year of CarbonSmart products from waste feedstock

LanzaTech’s fermentation process uses rabbit-gut bacteria to ferment gas pollution (contains CO2) captured from factories and municipal solid waste.
The bacteria then transforms those wastes to make its proprietary blend of ethanol it calls Lanzanol. Ethanol is a basic building block of many materials and it’s an alcohol that is blended with gasoline to lessen the fuel used by cars.
LanzaTech’s CEO, Jennifer Holmgren said that steel mills usually flare carbon monoxide (CO) and CO2 into the atmosphere. She noted:

“LanzaTech runs a plant at a steel-mill site, to easily grab the carbon monoxide emissions and put them into a reactor, a process called gas fermentation. Then, a unique strain of bacteria inside the reactor devours the emissions and “poops out ethanol, basically.” Holmgren added, “Fossil fuel is in everything we use, not just fuel or energy… dresses [SAF and other sustainable products] will show people that to decarbonize, we have to change where carbon in everything comes from.”

Cour Pharma Expands at ISTP
To meet the increasing demand for medical research space in the Chicagoland area, Cour Pharmaceuticals' life science and emerging biotechnology footprint is expanding within the Illinois Science and Technology Park in Skokie, Ill. With the addition, Cour Pharmaceuticals now leases around 25,000 sq. ft. in the park.

COUR Pharmaceuticals is developing first-in-class therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. COUR's platform of immune-modifying nanoparticles treats the root cause of immune disease, unlike traditional approaches, which only minimize symptoms using toxic immune suppression.
"Continued rapid growth for high-potential life science startups are emerging in Chicago and in addition to talent, life sciences companies like COUR will continue to need access to more specialized wet and dry lab space along with capital," said COUR Pharmaceuticals CEO John Puisis.

NorthShore University HealthSystem Nationally Ranked in U.S. News & World Report’s Annual Best Hospitals Listing
NorthShore University HealthSystem (NorthShore), including Northwest Community Healthcare (NCH), is among the top 50 hospitals in the country for Orthopedics, Diabetes & Endocrinology and Urology in U.S. News & World Report’s annual “Best Hospitals” survey for 2022-23. Additionally, the report ranked NorthShore as the #4 health system in both Illinois and the Chicago metro area.

The NorthShore Orthopaedic & Spine Institute, based at Skokie Hospital, climbed to #29 this year—a significant jump from its debut on the national list last year. NorthShore also ranked nationally in Diabetes & Endocrinology at #18, and NCH came in at #46 in Urology.

“We are honored to be recognized and grateful for the hard work of our team members who demonstrate clinical excellence across a broad spectrum of specialties that includes the most complex, high-risk conditions,” said Sean O’Grady, President North Region & Institutes. “These rankings also reflect our organization’s steadfast commitment to safe, seamless and personal care for our patients and communities.”

Noted Jason Koh, MD, The NorthShore Orthopaedic & Spine Institute’s Director and Mark R. Neaman Family Chair of Orthopaedic Surgery, “Our orthopaedic experts are world-leading surgeons, researchers, and specialists working with an exceptional dedicated team of anesthesiologists, nurses, assistants. We're honored to have our teamwork and collaboration be recognized once again as one of the nation's best hospitals for orthopaedics. We look forward to continuing our mission to develop and deliver the best possible care to restore our patients to pain-free mobility.”
Big Thinking at the Nanoscale: IIN Symposium
The 2022 IIN Symposium will, for the first time, exclusively feature luminaries from Northwestern delivering TED-style talks on their research and its impact across areas of importance to everyone. The winners of the 2021 Kabiller Prize in Nanoscience and Nanomedicine, Kabiller Young Investigator Award, and Kabiller Rising Star Award will also present their work.

Hosted by Chad Mirkin, George B. Rathmann Professor of Chemistry; Director, IIN

-Nanotechnology’s Importance to the World and Northwestern
-Regenerative Medicine
-Nanotechnology and Cancer
-Nanotechnology for Human Performance
-Nanotechnology Mimicking Living Systems
-Nanotechnology for Air and Water Security
-Artificial Intelligence in Nanotechnology
-Kabiller Award Presentations
October 27, 2022 9:00 am - 6:00 pm

Illinois Science + Technology Park (ISTP) is proud to be one of the sponsors of this event. To Learn more, click here.
Charles River Laboratories:
CDMOs can help clients smooth commercial cell and gene therapy (CGT) manufacturing demand 
It’s well known in the cell and gene therapy field that demand outstrips supply in the cell and gene therapy manufacturing space. CDMOs can help clients smooth commercial cell and gene therapy manufacturing demand.

Manufacturing is only one part of a CGT therapy’s lifecycle. Discovery, safety assessment, regulatory support, and testing are also required. Companies often outsource to a CRO for much of these ancillary services.

Partnering with a company early that can provide assistance in process development and has experience developing processes with commercialization in mind can offer a significant guiding hand to develop a robust and reproducible process with the proper critical process parameter (CPPs) and critical quality attributes (CQAs). Having this same company involved with your safety testing and release testing provides for a unique synergy for CGT assets creating significant opportunities for time and cost savings.
This information came from an article by Matt Hewitt of Charles River Labs. Charles River Labs is an industry-leading contract development and manufacturing organization (CDMO) that CGT companies depend upon to manufacture their cell and gene therapies for preclinical, clinical, and commercial uses.

Cyclopure Installs DEXSORB System 
Together with AECOM, Cyclopure has installed a DEXSORB packed-bed filtration (PBF) system in California to treat PFAS in AFFF-contaminated groundwater.

The DEXSORB pilot PBF system, configured with two pressurized vessels in lead-lag operation, and a telemetry monitoring system began operation on July 6th.
The skid-mounted system is scheduled to continue operation for six months. The company now has four operating pilots in the U.S., with three more pilot systems planned for installation during the 4th quarter.

Chicago: Among the Best Cities in the World
Time Out revealed its 53 best cities in the world list on Monday. Chicago ranks second following Edinburgh and is the only U.S. city that made the top 10, beating out New York, San Francisco and other domestic metropolises.

The global media brand’s annual list is based on poll responses from readers around the world along with input from contributors and experts. The Time Out Index 2022 asked respondents to rank their city’s bar and restaurant scene, its art and cultural offerings, whether its amenable to dating and meeting new people, its natural beauty and even its collective resiliency. To access this article from Crain's, click here.
Vetter Development Service @ISTP
Check out Skokie Farmers' Market